Albert David

{
  "main_header": {
    "sid": 876497,
    "name": "Albert David",
    "stock_name": "Albert David",
    "full_name": "Albert David Ltd",
    "name_url": "stocks-analysis/albert-david",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "715.15",
    "chg": 5.2,
    "chgp": "0.73%",
    "dir": 1,
    "prev_price": "709.95",
    "mcapval": "407.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524075,
    "symbol": "ALBERTDAVD",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE155C01010",
    "curr_date": "Jun 19, 03:30 PM",
    "curr_time": "23:31 PM",
    "last_traded_at": "Jun 19, 03:30 PM IST",
    "bse_nse_vol": "1.54 k",
    "exc_status": "Active",
    "traded_date": "Jun 19, 2026",
    "traded_date_str": "2026 06 19",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/albert-david-876497-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Albert David Ltd Upgraded to Sell as Technicals Improve Amidst Flat Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/albert-david-ltd-upgraded-to-sell-as-technicals-improve-amidst-flat-financials-4055443",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AlbertDavidLtd_mojoScore_4055443.png",
        "date": "2026-06-16 08:49:16",
        "description": "Albert David Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Strong Sell to Sell as of 15 June 2026. This change reflects nuanced shifts across technical indicators, valuation metrics, financial trends, and overall quality assessments, signalling a cautious but slightly less negative outlook for investors."
      },
      {
        "title": "Albert David Ltd Downgraded to Strong Sell Amidst Deteriorating Fundamentals and Bearish Technicals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/albert-david-ltd-downgraded-to-strong-sell-amidst-deteriorating-fundamentals-and-bearish-technicals-4040536",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AlbertDavidLtd_mojoScore_4040536.png",
        "date": "2026-06-09 08:55:42",
        "description": "Albert David Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has been downgraded from a Sell to a Strong Sell rating by MarketsMOJO as of 8 June 2026. This revision reflects deteriorating technical indicators, stagnant financial performance, and unfavourable valuation metrics, signalling heightened risk for investors in the stock currently trading at ₹696.40."
      },
      {
        "title": "Albert David Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/albert-david-ltd-is-rated-sell-4013491",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AlbertDavidLtd_mojoScore_4013491.png",
        "date": "2026-05-26 10:10:29",
        "description": "Albert David Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 11 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 26 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Albert David Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/albert-david-ltd-is-rated-sell-3992538",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AlbertDavidLtd_mojoScore_3992538.png",
        "date": "2026-05-15 10:10:26",
        "description": "Albert David Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 11 Feb 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 15 May 2026, providing investors with an up-to-date view of its fundamentals, returns, and overall outlook."
      },
      {
        "title": "Are Albert David Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-albert-david-ltd-latest-results-good-or-bad-3989986",
        "imagepath": "",
        "date": "2026-05-13 19:20:58",
        "description": "Albert David Ltd's latest financial results for Q4 FY26 indicate significant operational challenges. The company reported net sales of ₹85.86 crores, reflecting a year-on-year growth of 14.65% compared to ₹74.89 crores in Q4 FY25. However, this growth is overshadowed by a sequential decline of 4.53% from the previous quarter, Q3 FY26, where net sales were ₹89.93 crores.\n\nThe net profit for the quarter was a loss of ₹21.43 crores, a stark contrast to a profit of ₹15.30 crores in Q3 FY26. This represents a substantial deterioration in profitability, driven primarily by a negative other income adjustment of ₹24.84 crores. The operating margin also fell sharply to 3.20%, down from 12.03% in the previous quarter, highlighting severe cost pressures and operational inefficiencies.\n\nFor the full fiscal year FY26, Albert David's performance continued to reflect these struggles, with net sales declining by 4.70% to ₹..."
      },
      {
        "title": "Albert David Q4 FY26: Sharp Loss Derails Recovery Momentum",
        "link": "https://www.marketsmojo.com/news/result-analysis/albert-david-q4-fy26-sharp-loss-derails-recovery-momentum-3989524",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AlbertDavid_quaterlyResult_3989524.png",
        "date": "2026-05-13 09:51:45",
        "description": "Albert David Ltd., a Kolkata-based pharmaceutical manufacturer under the Kothari Group, reported a startling quarterly loss of ₹21.43 crores for Q4 FY26, marking a dramatic reversal from the ₹15.30 crore profit posted in the previous quarter. The unexpected downturn, representing a 107.50% quarter-on-quarter decline, has sent the stock tumbling 7.74% to ₹716.00, erasing gains and pushing the micro-cap pharma company deeper into valuation concerns."
      },
      {
        "title": "When is the next results date for Albert David Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-albert-david-ltd-3976544",
        "imagepath": "",
        "date": "2026-05-05 23:16:42",
        "description": "The next results date for Albert David Ltd is scheduled for 12 May 2026...."
      },
      {
        "title": "Albert David Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/albert-david-ltd-is-rated-sell-3973257",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AlbertDavidLtd_mojoScore_3973257.png",
        "date": "2026-05-04 10:10:03",
        "description": "Albert David Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 11 Feb 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 04 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Albert David Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/albert-david-ltd-is-rated-sell-3959077",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AlbertDavidLtd_mojoScore_3959077.png",
        "date": "2026-04-23 10:10:04",
        "description": "Albert David Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 11 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 April 2026, providing investors with an up-to-date view of the company's fundamentals, returns, and market standing."
      }
    ],
    "total": 175,
    "sid": "876497",
    "stock_news_url": "https://www.marketsmojo.com/news/albert-david-876497"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "19-Jun-2026",
      "details": "Appointment of Mr. Amit Mahla as Additional Director and Whole-time Director & CEO w.e.f 19th June 2026",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Appointment Of Mr. Amit Mahla As An Additional Director And Whole-Time Director & CEO Of The Company And Fixed His Remuneration. Revised Notice Of 87Th AGM.",
      "datetime": "19-Jun-2026",
      "details": "Appointment of Mr. Amit Mahla as an Additional Director and Whole-time Director & CEO of the Company and fixed his remuneration. Revised Notice of 87th AGM.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "18-Jun-2026",
      "details": "Disclosure pursuant to Reg. 30 - Publication of Notice in Newspapers for transfer of equity shares of the Company to the Investor Education and Protection Fund",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Albert David Ltd has declared <strong>50%</strong> dividend, ex-date: 30 Jul 26",
          "dt": "2026-07-30",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Albert David Ltd Upgraded to Sell as Technicals Improve Amidst Flat Financials

2026-06-16 08:49:16

Albert David Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Strong Sell to Sell as of 15 June 2026. This change reflects nuanced shifts across technical indicators, valuation metrics, financial trends, and overall quality assessments, signalling a cautious but slightly less negative outlook for investors.

Read full news article

Albert David Ltd Downgraded to Strong Sell Amidst Deteriorating Fundamentals and Bearish Technicals

2026-06-09 08:55:42

Albert David Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has been downgraded from a Sell to a Strong Sell rating by MarketsMOJO as of 8 June 2026. This revision reflects deteriorating technical indicators, stagnant financial performance, and unfavourable valuation metrics, signalling heightened risk for investors in the stock currently trading at ₹696.40.

Read full news article

Albert David Ltd is Rated Sell

2026-05-26 10:10:29

Albert David Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 11 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 26 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Albert David Ltd is Rated Sell

2026-05-15 10:10:26

Albert David Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 11 Feb 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 15 May 2026, providing investors with an up-to-date view of its fundamentals, returns, and overall outlook.

Read full news article

Are Albert David Ltd latest results good or bad?

2026-05-13 19:20:58

Albert David Ltd's latest financial results for Q4 FY26 indicate significant operational challenges. The company reported net sales of ₹85.86 crores, reflecting a year-on-year growth of 14.65% compared to ₹74.89 crores in Q4 FY25. However, this growth is overshadowed by a sequential decline of 4.53% from the previous quarter, Q3 FY26, where net sales were ₹89.93 crores. The net profit for the quarter was a loss of ₹21.43 crores, a stark contrast to a profit of ₹15.30 crores in Q3 FY26. This represents a substantial deterioration in profitability, driven primarily by a negative other income adjustment of ₹24.84 crores. The operating margin also fell sharply to 3.20%, down from 12.03% in the previous quarter, highlighting severe cost pressures and operational inefficiencies. For the full fiscal year FY26, Albert David's performance continued to reflect these struggles, with net sales declining by 4.70% to ₹...

Read full news article

Albert David Q4 FY26: Sharp Loss Derails Recovery Momentum

2026-05-13 09:51:45

Albert David Ltd., a Kolkata-based pharmaceutical manufacturer under the Kothari Group, reported a startling quarterly loss of ₹21.43 crores for Q4 FY26, marking a dramatic reversal from the ₹15.30 crore profit posted in the previous quarter. The unexpected downturn, representing a 107.50% quarter-on-quarter decline, has sent the stock tumbling 7.74% to ₹716.00, erasing gains and pushing the micro-cap pharma company deeper into valuation concerns.

Read full news article

When is the next results date for Albert David Ltd?

2026-05-05 23:16:42

The next results date for Albert David Ltd is scheduled for 12 May 2026....

Read full news article

Albert David Ltd is Rated Sell

2026-05-04 10:10:03

Albert David Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 11 Feb 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 04 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Albert David Ltd is Rated Sell

2026-04-23 10:10:04

Albert David Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 11 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 April 2026, providing investors with an up-to-date view of the company's fundamentals, returns, and market standing.

Read full news article

View All News